"A few issues are more debated today than the price of pharmaceuticals. The debate is prompted by the lack of drug access for the world's population, the high expenditures of pharmaceutical companies in marketing and profits, and the need for research and development of new drugs."
Seoane-Vazquez E. Price of pharmaceuticals, value, R&D, and intergenerational equity. Electronic Journal of Biomedicine. 2003;1(2):108-111.